Outlook Therapeutics OTLK
NASDAQ OTLK
$0.59 +0.02 (+3.51%)
At close: Oct 2, 2026 · 4:00 PM EDT

Outlook Therapeutics (OTLK) Return on Assets [ROA] (2016 - 2026)

Updated

Outlook Therapeutics' Return on Assets [ROA] came in at -214.44% for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 183.11 percentage points from -397.55% a year earlier and up 41.63 percentage points from the prior quarter.

Analysis

Outlook Therapeutics (OTLK) Return on Assets [ROA] (2016 - 2026) Analysis & Trends

For FY2025 (ended Sep 30, 2025), Outlook Therapeutics' Return on Assets [ROA] was -263.36%, down 16.75 percentage points from FY2024.

  • Return on Assets [ROA] carries a five-year change of -72.19 percentage points (FY2020 to FY2025).
  • Going back by fiscal year, Return on Assets [ROA] was -246.60% in FY2024 (-52.67 pp), -193.93% in FY2023 (+63.39 pp), -257.32% in FY2022 (-7.40 pp) and -249.92% in FY2021 (-58.75 pp).
  • The fiscal Q3 2026 figure represents the highest quarterly Return on Assets [ROA] since fiscal Q2 2025.
  • Year-over-year, Return on Assets [ROA] increased in two of the last eight quarters, with an average year-over-year change of -71.35 percentage points.
  • The fastest year-over-year change in Return on Assets [ROA] over five years came in fiscal Q2 2025 (a gain of 293.18 percentage points), and the weakest in fiscal Q2 2024 (a drop of 299.27 percentage points).
  • Business Quant data shows OTLK's Return on Assets [ROA] at -256.07% (Q2 2026), -506.68% (Q1 2026) and -494.97% (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Outlook Therapeutics 80.68 Mn 44.93 Mn -8,265.00 -214.44%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -214.44%
Mar 31, 2026 -256.07%
Dec 31, 2025 -506.68%
Sep 30, 2025 -494.97%
Jun 30, 2025 -397.55%
Mar 31, 2025 -99.02%
Dec 31, 2024 -374.41%
Sep 30, 2024 -196.30%
Jun 30, 2024 -175.64%
Mar 31, 2024 -392.20%
Dec 31, 2023 -187.62%
Sep 30, 2023 -145.95%
Jun 30, 2023 -116.51%
Mar 31, 2023 -92.92%
Dec 31, 2022 -147.51%
Sep 30, 2022 -192.92%
Jun 30, 2022 -120.06%
Mar 31, 2022 -79.88%
Dec 31, 2021 -102.19%
Sep 30, 2021 -190.54%
API Access

Outlook Therapeutics Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=OTLK&period=max&api_key=YOUR_API_KEY